MainStreet Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Sell
30,745
-188
-0.6% -$21.7K 0.56% 47
2025
Q4
$3.26M Sell
30,933
-2,383
-7% -$224K 0.47% 57
2025
Q3
$2.8M Sell
33,316
-2,401
-7% -$198K 0.38% 63
2025
Q2
$2.83M Sell
35,717
-1,892
-5% -$150K 0.39% 66
2025
Q1
$3.38M Buy
37,609
+44
+0.1% +$4.11K 0.49% 57
2024
Q4
$3.74M Sell
37,565
-1,524
-4% -$157K 0.52% 52
2024
Q3
$4.44M Sell
39,089
-15,211
-28% -$1.81M 0.59% 45
2024
Q2
$6.72M Sell
54,300
-5,850
-10% -$754K 0.82% 33
2024
Q1
$7.94M Sell
60,150
-960
-2% -$118K 0.95% 29
2023
Q4
$6.66M Sell
61,110
-1,538
-2% -$160K 0.75% 34
2023
Q3
$6.45M Sell
62,648
-753
-1% -$81.2K 0.75% 35
2023
Q2
$7.32M Buy
63,401
+2,818
+5% +$320K 0.79% 35
2023
Q1
$6.45M Buy
60,583
+6,382
+12% +$689K 0.7% 40
2022
Q4
$6.01M Buy
54,201
+144
+0.3% +$14.7K 0.67% 43
2022
Q3
$4.66M Hold
54,057
0.57% 50
2022
Q2
$4.93M Sell
54,057
-2,030
-4% -$180K 0.57% 48
2022
Q1
$4.6M Sell
56,087
-149
-0.3% -$11.7K 0.43% 62
2021
Q4
$4.31M Sell
56,236
-1,495
-3% -$119K 0.38% 66
2021
Q3
$4.34M Sell
57,731
-4,996
-8% -$380K 0.42% 66
2021
Q2
$4.88M Sell
62,727
-8,643
-12% -$643K 0.42% 71
2021
Q1
$5.25M Sell
71,370
-3,073
-4% -$227K 0.44% 64
2020
Q4
$5.81M Sell
74,443
-6,419
-8% -$491K 0.46% 61
2020
Q3
$6.4M Buy
80,862
+32,297
+67% +$2.53M 0.5% 55
2020
Q2
$3.58M Buy
48,565
+20,575
+74% +$1.55M 0.25% 74
2020
Q1
$2.06M Buy
27,990
+12,374
+79% +$972K 0.25% 73
2019
Q4
$1.35M Buy
15,616
+2,092
+15% +$172K 0.15% 83
2019
Q3
$1.09M Sell
13,524
-487
-3% -$39K 0.14% 82
2019
Q2
$1.12M Sell
14,011
-1,405
-9% -$108K 0.15% 82
2019
Q1
$1.22M Buy
15,416
+786
+5% +$58.8K 0.17% 75
2018
Q4
$1.07M Buy
14,630
+66
+0.5% +$4.66K 0.16% 80
2018
Q3
$986K Buy
14,564
+6,621
+83% +$422K 0.13% 85
2018
Q2
$460K Sell
7,943
-1,381
-15% -$77.9K 0.07% 115
2018
Q1
$485K Sell
9,324
-1,308
-12% -$70.6K 0.07% 109
2017
Q4
$571K Buy
+10,632
New +$589K 0.09% 108

Other funds holding MRK

MainStreet Investment Advisors's MRK Position: Q1 2026 in Review

MainStreet Investment Advisors reduced its Merck (MRK) stake by 0.61% in Q1 2026, selling an estimated $21.7K and leaving 30,745 shares worth $3.7M. The position accounts for 0.56% of the portfolio, ranked #47.

MainStreet Investment Advisors first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $7.94M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • MainStreet Investment Advisors held 30,745 shares of Merck worth $3.7M as of Q1 2026.
  • MainStreet Investment Advisors sold 188 Merck shares in Q1 2026, an estimated $21.7K.
  • Merck made up 0.56% of MainStreet Investment Advisors's portfolio in Q1 2026, its #47 holding.
  • MainStreet Investment Advisors first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
  • MainStreet Investment Advisors's Merck position peaked at $7.94M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on MainStreet Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.